Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cantel Medical Reports Net Income up 39% on 43% Increase in Net Sales for Quarter Ended April 30, 2004; EPS - $0.30 vs. $0.23 for Quarter; $0.74 vs. $0.60 for Nine Months.


Business Editors/Health/Medical Writers

LITTLE FALLS Little Falls is the name of some places in the United States of America:
  • Little Falls, Minnesota
  • Little Falls, New Jersey
  • Little Falls (city), New York
  • Little Falls (town), New York
, N.J.--(BUSINESS WIRE)--June 3, 2004

Cantel Medical Corp. (NYSE NYSE

See: New York Stock Exchange
:CMN CMN Common
CMN Children's Miracle Network (since 1983; Salt Lake City, Utah)
CMN Certificate of Medical Necessity
CMN Canadian Museum of Nature
CMN Community Mapping Network
CMN Common Information
) reported net income of $3,094,000, an increase of 39%, or $0.30 per diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 share, on sales of $46,898,000, an increase of 43%, for its third quarter ended April 30, 2004, as compared with net income of $2,223,000, or $0.23 per diluted share, on sales of $32,848,000 for the quarter ended April 30, 2003. Of the 43% increase in net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
, 24% of the increase was from the company's core businesses and 19% was from the water treatment acquisitions.

For the nine months ended April 30, 2004, the Company reported net income of $7,462,000, an increase of 27%, or $0.74 per diluted share, on sales of $124,843,000, an increase of 31%, as compared with net income of $5,872,000, or $0.60 per diluted share, on sales of $95,648,000 for the nine months ended April 30, 2003. Of the 31% increase in net sales, 14% was from the company's core businesses and 17% was from the water treatment acquisitions.

The Company further reported that its balance sheet at April 30, 2004 showed current assets Current Assets

Appearing on a company's balance sheet, it represents cash, accounts receivable, inventory, marketable securities, prepaid expenses, and other assets that can be converted to cash within one year.
 of $70,334,000, including cash of $14,700,000, a current ratio of 2.85:1, a ratio of funded debt Funded Debt

Long-term debt that matures after more than one year.

Notes:
This is usually issued as a bond or a long-term note.
See also: Bond, Debt, Maturity, Note



Funded debt

Debt maturing after more than one year.
 to equity of .28:1 and stockholders' equity Stockholders' Equity

The portion of the balance sheet that includes capital received from investors in exchange for stock (paid-in capital), donated capital, and retained earnings. This is equal to total assets minus liabilities, preferred stock and intangible assets.
 of $80,999,000.

James P. Reilly, President and Chief Executive Officer of CANTEL, commented, "Increased revenues in all of our business segments contributed to the outstanding results in our third quarter." Reilly added, "Based upon the strong results for the first nine months and the contribution from the recently acquired water treatment and specialty packaging businesses we expect a strong finish to fiscal 2004 and improved operating results in fiscal 2005."

Cantel Medical Corp., a healthcare company, is a leading provider of infection prevention and control products, specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 medical device reprocessing Reprocessing may refer to:
  • Nuclear reprocessing
  • Recycling
 systems for renal renal /re·nal/ (re´n'l) pertaining to the kidney.

re·nal
adj.
Of or in the region of the kidneys.


Renal
Relating to the kidney.
 dialysis dialysis (dīăl`ĭsĭs), in chemistry, transfer of solute (dissolved solids) across a semipermeable membrane. Strictly speaking, dialysis refers only to the transfer of the solute; transfer of the solvent is called osmosis.  and endoscopy endoscopy

Examination of the body's interior through an instrument inserted into a natural opening or an incision, usually as an outpatient procedure. Endoscopes include the upper gastrointestinal endoscope (for the esophagus, stomach, and duodenum), the colonoscope (for the
, water treatment systems, sterilants, diagnostic imaging and therapeutic medical equipment primarily focused on endoscopy, hollow fiber membrane filtration filtration: see sewerage; water supply.
Filtration

The separation of solid particles from a fluidsolids suspension of which they are a part by passage of most of the fluid through a septum or membrane that retains most of the solids
 and separation technologies for medical and non-medical applications, specialized packaging for infectious and biological specimens, and scientific instrumentation instrumentation, in music: see orchestra and orchestration.
instrumentation

In technology, the development and use of precise measuring, analysis, and control equipment.
. The Company also provides technical maintenance services for its products.

The Company will hold a conference call to discuss the results for the third quarter ended April 30, 2004 and the recently completed acquisition of SAF-T-PAK, a niche company providing products and training services for the safe transportation of infectious and biological specimens such as human and animal blood, tissue samples, vaccines, etc., on Thursday, June 3, 2004 at 11:00 AM Eastern time. To participate in the conference call, dial 1-877-407-8035 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, June 3 at 2:00 PM through midnight on June 4, by dialing 1-877-660-6853 and using passcode #1628 and conference ID #107243. The call will be simultaneously broadcast live over the Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 on vcall.com at http://www.vcall.com/CEPage.asp?ID=88329. A replay of the webcast will be available on Vcall for 30 days.

For further information, visit the Cantel Web site at www.cantelmedical.com.

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. All forward-looking statements involve risks and uncertainties, including, without limitation, the risks detailed in the Company's filings and reports with the Securities and Exchange Commission. Such statements are only predictions, and actual events or results may differ materially from those projected.

                         CANTEL MEDICAL CORP.
             CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                (In thousands, except per share data)

                                 Three Months Ended Nine Months Ended
                                     April 30,          April 30,
                                 ------------------ ------------------
                                   2004     2003      2004     2003
                                 --------- -------- --------- --------

Net sales                         $46,898  $32,848  $124,843  $95,648

Cost of sales                      29,646   20,454    79,299   59,940
                                 --------- -------- --------- --------

Gross profit                       17,252   12,394    45,544   35,708

Operating expenses:
  Selling                           5,316    4,392    15,017   12,648
  General and administrative        5,402    3,259    13,976    9,556
  Research and development          1,100      914     3,273    3,184
                                 --------- -------- --------- --------
Total operating expenses           11,818    8,565    32,266   25,388
                                 --------- -------- --------- --------

Income before interest and
 income taxes                       5,434    3,829    13,278   10,320

Interest expense - net                374      298     1,205    1,061
                                 --------- -------- --------- --------

Income before income taxes          5,060    3,531    12,073    9,259

Income taxes                        1,966    1,308     4,611    3,387
                                 --------- -------- --------- --------

Net income                         $3,094   $2,223    $7,462   $5,872
                                 ========= ======== ========= ========

Earnings per common share -
 diluted                            $0.30    $0.23     $0.74    $0.60
                                 ========= ======== ========= ========

Weighted average shares -
 diluted                           10,215    9,835    10,053    9,834



                         CANTEL MEDICAL CORP.
                CONDENSED CONSOLIDATED BALANCE SHEETS
                            (In thousands)

                                                   April 30, July 31,
                                                     2004      2003
                                                   --------- ---------
     Assets
Current assets                                      $70,334   $61,930
Property and equipment, net                          22,854    22,161
Intangible assets                                    10,251     6,998
Goodwill                                             27,959    16,398
Other assets                                          2,441     2,323
                                                   --------- ---------
                                                   $133,839  $109,810
                                                   ========= =========

     Liabilities and stockholders' equity
Current liabilities                                 $24,703   $18,287
Long-term liabilities                                28,137    21,341
Stockholders' equity                                 80,999    70,182
                                                   --------- ---------
                                                   $133,839  $109,810
                                                   ========= =========
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 3, 2004
Words:859
Previous Article:RBC Receives Corporate Governance Rating at B++.
Next Article:Enerjy Software to Introduce Pioneering Business Model, Announce Latest Product Updates at JavaOne.



Related Articles
Cantel Industries reports increased sales and earnings for the quarter and nine months ended April 30, 1997.
Cantel Medical Reports 53% Increase in Earnings Per Share From Continuing Operations On 156% Increase in Net Sales for Quarter Ended April 30, 2002.
Cantel Medical Reports Record Results; Income From Continuing Operations Increases 43% for Quarter and 72% for Year Ended July 31, 2002.
Cantel Medical Reports Results for Quarter Ended April 30, 2003; EPS - $0.23 Vs. $0.23 For Quarter; $0.60 Vs. $0.54 For Nine Months.
Cantel Medical Reports Results for Quarter and Year Ended July 31, 2003; EPS - $0.21 vs. $0.20 Quarter; $0.80 vs. $0.74 Year.
Gorman-Rupp Reports Increases in Third Quarter 2003.
Hibbett Reports Third Quarter Results.
Third quarter improvements reported by Home Properties.
Cantel Medical Reports EPS of $0.23 vs. $0.20 on 23% Increase in Net Income for Quarter Ended April 30, 2005; Canadian Distribution Agreements with...
Cantel Medical Reports Results for Quarter Ended April 30, 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles